Frequent occurrence of gastric cancer in Asian kindreds with Li-Fraumeni syndrome

Clinical Genetics

Volumn 88, Issue 5, 2015, Pages 450-455

  Ariffin, H ^a,b   Chan, A S L ^b   Oh, L ^a   Abd Ghafar, S ^a   Ong, G B ^c   Mohamed, M ^d   Razali, H ^e   Juraida, E ^d   Teo, S H ^f   Karsa, M ^a   Shamsani, J ^a   Hainaut, P ^g  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^c SARAWAK GENERAL HOSPITAL   (Malaysia)

^d Haematology Oncology Unit   (Malaysia)

^e Hospital Sultan Ismail   (Malaysia)

^f CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^g UNIV GRENOBLE ALPES   (France)

Author keywords

Cancer risk; Gastric cancer; Li Fraumeni syndrome; TP53

Indexed keywords

PROTEIN P53; TP53 PROTEIN, HUMAN;

ARTICLE; ASIAN; CANCER INCIDENCE; CAUCASIAN; DNA BINDING; FAMILIAL CANCER; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; POPULATION RISK; PRIORITY JOURNAL; STOMACH CANCER; ASIAN CONTINENTAL ANCESTRY GROUP; COMPLICATION; GENETICS; MUTATION; STOMACH NEOPLASMS;

ASIAN CONTINENTAL ANCESTRY GROUP; HUMANS; LI-FRAUMENI SYNDROME; MUTATION; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84943258748     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12525     Document Type: Article

References (20)

1. Malkin D. Li-fraumeni syndrome. Genes Cancer 2011: 2 (4): 475-484.
2. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 2002: 19 (6): 607-614.
3. Ruijs MW, Verhoef S, Rookus MA et al. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J Med Genet 2010: 47 (6): 421-428.
4. Bougeard G, Sesboue R, Baert-Desurmont S et al. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. J Med Genet 2008: 45 (8): 535-538.
5. Tinat J, Bougeard G, Baert-Desurmont S et al. 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol 2009: 27 (26): e108-e109, author reply e10.
6. Williams AC, Miller JC, Collard T, Browne SJ, Newbold RF, Paraskeva C. The effect of different TP53 mutations on the chromosomal stability of a human colonic adenoma derived cell line with endogenous wild type TP53 activity, before and after DNA damage. Genes Chromosomes Cancer 1997 Sep: 20 (1): 44-52.
7. Choong SS, Latiff ZA, Mohamed M et al. Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations. Clin Genet 2012: 82: 564-568.
8. Villani A, Tabori U, Schiffman J et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol 2011: 12: 559-567.
9. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 1994: 265 (5170): 346-355.
10. Bell DW, Varley JM, Szydlo TE et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni Syndrome. Science 1999: 286 (5449): 2528-2531.
11. Lalloo F, Varley J, Ellis D et al. Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet 2003: 361 (9363): 1101-1102.
12. Gonzalez KD, Noltner KA, Buzin CH et al. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 2009: 27 (8): 1250-1256.
13. Wong P, Verselis SJ, Garber JE et al. Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology 2006: 130 (1): 73-79.
14. Milne AN, Offerhaus GJ. Early-onset gastric cancer: learning lessons from the young. World J Gastrointest Oncol 2010: 2 (2): 59-64.
15. Oliveira C, Suriano G, Ferreira P et al. Genetic screening for familial gastric cancer. Hered Cancer Clin Pract 2004: 2 (2): 51-64.
16. Qiao W, Wang T, Zhang L, Tang Q, Wang D, Sun H. Association study of single nucleotide polymorphisms in XRCC1 gene with the risk of gastric cancer in Chinese population. Int J Biol Sci 2013: 9 (7): 753-758.
17. Chu H, Zhao Q, Wang S et al. Tagging SNPs in the ERCC4 gene are associated with gastric cancer risk. Gene 2013: 521 (1): 50-54.
18. Lee J, Kim DH, Lee S et al. A tumor suppressive coactivator complex of p53 containing ASC-2 and histone H3-lysine-4 methyltransferase MLL3 or its paralogue MLL4. Proc Natl Acad Sci U S A 2009: 106 (21): 8513-8518.
19. Lee DS, Yoon SY, Looi LM et al. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients. Breast Cancer Res 2012: 14 (2): R66.
20. Jeon C, Chang S, Mu L et al. Genetic variants of peroxisome proliferator-activated receptor δ are associated with gastric cancer. Dig Dis Sci 2013: 58 (10): 2881-2886.